Elizabeth R. Plimack
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers 138
- Pancreatic and Hepatic Oncology Research 28
- Pulmonary and Respiratory Medicine top 0.1%
- Renal cell carcinoma treatment 139
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 45
- Surgery top 0.2%
- Bladder and Urothelial Cancer Treatments 142
- Urinary and Genital Oncology Studies 85
- Immunology top 1%
-
- Renal and related cancers 41
-
- Economic and Financial Impacts of Cancer 26
- Co-authors
- Brian I. RiniDavid F. McDermottHans J. HammersSaby GeorgeSumanta K. PalPadmanee SharmaNoah M. HahnJoaquim Bellmunt
- Journals
- Journal of Clinical Oncology (153 papers)Annals of Oncology (21 papers)The Journal of Urology (12 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Elizabeth R. Plimack
302 papers receiving 13.9k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 7.9k
- Pulmonary and Respiratory Medicine 6.3k
- Cancer Research 2.4k
- Surgery 5.8k
- Immunology 1.9k
Countries citing papers authored by Elizabeth R. Plimack
This map shows the geographic impact of Elizabeth R. Plimack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth R. Plimack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth R. Plimack more than expected).
Fields of papers citing papers by Elizabeth R. Plimack
This network shows the impact of papers produced by Elizabeth R. Plimack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth R. Plimack. The network helps show where Elizabeth R. Plimack may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Elizabeth R. Plimack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 9 | |
| 8 | 2023 | 19 | |
| 9 | 2022 | 27 | |
| 10 | 2022 | 9 | |
| 11 | 2022 | 17 | |
| 12 | 2021 | 25 | |
| 13 | 2020 | 16 | |
| 14 | EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4–Positive Solid Tumors, Including Metastatic Urothelial Carcinomabreakdown → | 2020 | 223 |
| 15 | 2019 | 26 | |
| 16 | Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Studybreakdown → | 2017 | 348 |
| 17 | 2016 | 21 | |
| 18 | 2014 | 55 | |
| 19 | Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trialbreakdown → | 2014 | 865 |
| 20 | 2013 | 141 |
About Elizabeth R. Plimack
Elizabeth R. Plimack is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 317 papers that have together received 14.1k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (142 papers), Renal cell carcinoma treatment (139 papers), Cancer Immunotherapy and Biomarkers (138 papers), Urinary and Genital Oncology Studies (85 papers), Cancer Genomics and Diagnostics (45 papers), Renal and related cancers (41 papers), Pancreatic and Hepatic Oncology Research (28 papers) and Economic and Financial Impacts of Cancer (26 papers). The work is most often cited by research in Oncology (7.9k citations), Pulmonary and Respiratory Medicine (6.3k citations) and Cancer Research (2.4k citations). Elizabeth R. Plimack has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Brian I. Rini, David F. McDermott, Hans J. Hammers, Saby George, Sumanta K. Pal, Padmanee Sharma, Noah M. Hahn, Joaquim Bellmunt, Robert J. Motzer and Peter H. O’Donnell. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Journal of Urology, European Urology Oncology and Clinical Genitourinary Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.